Treace Medical Concepts, Inc. (TMCI)

Treace Medical Concepts Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	8.05	11.35	12.98	19.47	105.83	18.08
Short-Term Investments	61.24	64.33	110.22	61.78	-	-
Cash & Short-Term Investments	69.29	75.68	123.2	81.25	105.83	18.08
Cash Growth	-27.10%	-38.57%	51.63%	-23.23%	485.39%	48.93%
Accounts Receivable	30.33	40.8	38.06	29.2	18.57	14.49
Other Receivables	0.6	0.6	1.1	0.4	-	-
Receivables	30.93	41.4	39.16	29.6	18.57	14.49
Inventory	42.4	39.26	29.25	19.33	10.56	7.82
Prepaid Expenses	4.98	5.07	6.75	3.22	3.01	0.59
Total Current Assets	147.6	161.4	198.36	133.4	137.97	40.98
Property, Plant & Equipment	37.75	34.4	31.56	25.48	2.85	0.83
Goodwill	12.82	12.82	12.82	-	-	-
Other Intangible Assets	7.6	8.08	9.03	-	-	-
Other Long-Term Assets	0.68	0.41	0.15	0.15	-	-
Total Assets	206.44	217.09	251.91	159.02	140.82	41.81
Accounts Payable	19.96	10.52	11.84	8.67	4.06	2.27
Accrued Expenses	18.58	21.77	25.43	21.24	14.15	7.54
Current Portion of Long-Term Debt	-	-	-	-	-	1.79
Current Portion of Leases	2.09	0.41	1.4	0.34	-	-
Other Current Liabilities	0.15	2.22	6.37	-	-	-
Total Current Liabilities	41.9	34.93	45.03	30.25	18.21	11.6
Long-Term Debt	53.45	53.31	53.01	52.71	29.54	29.43
Long-Term Leases	13.44	15.93	15.89	15.54	-	-
Other Long-Term Liabilities	0.04	0.04	0.04	-	-	-
Total Liabilities	108.83	104.2	113.97	98.5	47.75	41.03
Common Stock	0.06	0.06	0.06	0.06	0.05	0.03
Additional Paid-In Capital	321.51	303	271.97	145.22	134.93	14.17
Retained Earnings	-223.31	-189.99	-134.25	-84.72	-41.91	-21.35
Treasury Stock	-0.7	-0.28	-0.01	-	-	-
Comprehensive Income & Other	0.05	0.1	0.16	-0.03	-	-
Total Common Equity	97.62	112.89	137.94	60.53	93.07	-7.16
Shareholders' Equity	97.62	112.89	137.94	60.53	93.07	0.78
Total Liabilities & Equity	206.44	217.09	251.91	159.02	140.82	41.81
Total Debt	70.09	69.65	70.3	68.59	29.54	31.22
Net Cash (Debt)	-0.81	6.02	52.9	12.66	76.3	-13.14
Net Cash Growth	-	-88.61%	317.71%	-83.40%	-	-
Net Cash Per Share	-0.01	0.10	0.87	0.23	1.58	-0.35
Filing Date Shares Outstanding	63.17	62.36	61.75	61.16	54.75	37.37
Total Common Shares Outstanding	63.04	62.36	61.75	55.63	54.18	37.37
Working Capital	105.7	126.48	153.33	103.16	119.76	29.38
Book Value Per Share	1.55	1.81	2.23	1.09	1.72	-0.19
Tangible Book Value	77.2	92	116.1	60.53	93.07	-7.16
Tangible Book Value Per Share	1.22	1.48	1.88	1.09	1.72	-0.19
Machinery	36.87	29.48	20.19	12.32	5.06	3.16
Construction In Progress	0.86	0.61	1.12	0.71	0.13	-
Leasehold Improvements	10.52	10.24	9.43	6.43	0.27	0.17

Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q